Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03044691 · ClinicalTrials.gov registry record · NA

The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care

A NA study, sponsored by University of Florida.

Terminated
Registry status
NA
Development phase
84
Enrollment target

NCT03044691: Clinical Trial NA study, sponsored by University of Florida.

NCT03044691 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03044691, a NA study, was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

The primary purpose of our study is to conduct a pilot, practice-based intervention focused on increasing adherence to the 6As for youth ages 11 through 17 years. The 6As are: (1) "Anticipate" (future use), (2) "Ask" (about tobacco use), (3) "Advise" (advise the patient to quit using tobacco), (4) "Assess" (the patient's readiness to quit using tobacco), (5) "Assist" (by setting a quit date, providing materials on quitting tobacco, providing tobacco cessation medications, and referring the patient for additional services and/or counseling) , and (6) "Arrange" (by re-contacting the patient after their quit date and arranging a follow-up visit).

Primary Outcome

During the recruitment period, investigators will observe feedback from patients and clinic staff on how the feasibility of using the ResearchACTS software to capture tobacco use measures in a clinical setting. Feasibility of the software tool will be demonstrated by the ability of patients to complete the assessment within the timeframe afforded during a clinical visit.

Interventions

  • BEHAVIORAL ResearchACTS software

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2017-02-27
Est. Completion 2017-11-11
Phase NA
University of Florida

1,106 total trials

Why NCT03044691 stopped before completion

NCT03044691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which ResearchACTS software is the first listed.

NCT03044691 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03044691 about?

NCT03044691 is a clinical study titled "The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care". The primary purpose of our study is to conduct a pilot, practice-based intervention focused on increasing adherence to the 6As for youth ages 11 through 17 years. The 6As are: (1) "Anticipate" (future use), (2) "Ask" (about tobacco use), (3) "Advise" (advise the patient to quit using tobacco), (4) "...

What is the current status of trial NCT03044691?

This trial is currently terminated. It is a NA study. The enrollment target is 84 participants. The study started on 2017-02-27. Estimated completion is 2017-11-11.

What interventions are being tested in trial NCT03044691?

The interventions under investigation include: ResearchACTS software (BEHAVIORAL).

Who is sponsoring clinical trial NCT03044691?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03044691's enrollment target sits among peer trials

84 983rd of 2000 higher than 1,011 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03044691, the US trial registry maintained by the National Library of Medicine. NCT03044691 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.